Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.
Saved in:
| Title: | Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction. |
|---|---|
| Authors: | Vaccaro K; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Allen J; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Whitfield TW; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Maoz A; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Reeves S; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Velarde J; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Yang D; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Meglan A; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Ribeiro J; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Blandin J; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Phan N; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Bell GW; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Hata AN; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Weiskopf K; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2024 Mar 14; Vol. 134 (9). Date of Electronic Publication: 2024 Mar 14. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
